Proteomic analysis of changes in protein expression in liver mitochondria in apoE knockout mice

Newmeyer, 2003, Mitochondria: releasing power for life and unleashing the machineries of death, Cell, 112, 481, 10.1016/S0092-8674(03)00116-8

Ballinger, 2002, Mitochondrial integrity and function in atherogenesis, Circulation, 106, 544, 10.1161/01.CIR.0000023921.93743.89

Wei, 2008, Nonalcoholic fatty liver disease and mitochondrial dysfunction, World J Gastroenterol, 14, 193, 10.3748/wjg.14.193

Yan, 2000, A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry, Electrophoresis, 21, 3666, 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6

Alaynick, 2008, Nuclear receptors, mitochondria and lipid metabolism, Mitochondrion, 8, 329, 10.1016/j.mito.2008.02.001

Guillen, 2009, Microarray analysis of hepatic gene expression identifies new genes involved in steatotic liver, Physiol Genomics, 37, 187, 10.1152/physiolgenomics.90339.2008

Chamero, 2007, Identification of protein pheromones that promote aggressive behaviour, Nature, 450, 899, 10.1038/nature05997

Hui, 2009, Major urinary protein-1 increases energy expenditure and improves glucose intolerance through enhancing mitochondrial function in skeletal muscle of diabetic mice, J Biol Chem, 284, 14050, 10.1074/jbc.M109.001107

Zhou, 2009, Identification of MUP1 as a regulator for glucose and lipid metabolism in mice, J Biol Chem, 284, 11152, 10.1074/jbc.M900754200

Dmitriev, 2010, Lipid peroxidation in relation to ageing and the role of endogenous aldehydes in diabetes and other age-related diseases, Ageing Res Rev, 9, 200, 10.1016/j.arr.2009.09.004

Thornalley, 2003, Glyoxalase I — structure, function and a critical role in the enzymatic defence against glycation, Biochem Soc Trans, 31, 1343, 10.1042/bst0311343

Creighton, 2003, Glyoxalase I inhibitors in cancer chemotherapy, Biochem Soc Trans, 31, 1378, 10.1042/bst0311378

Yesilova, 2005, Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease, Am J Gastroenterol, 100, 850, 10.1111/j.1572-0241.2005.41500.x

Torzewski, 2007, Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice, Arterioscler Thromb Vasc Biol, 27, 850, 10.1161/01.ATV.0000258809.47285.07

Cox, 2009, Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling, Biochem J, 425, 313, 10.1042/BJ20091541

Petrosillo, 2007, Mitochondrial dysfunction in rat with nonalcoholic fatty liver Involvement of complex I, reactive oxygen species and cardiolipin, Biochim Biophys Acta, 1767, 1260, 10.1016/j.bbabio.2007.07.011

Mehta, 2002, Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants, Nutr Rev, 60, 289, 10.1301/002966402320387224

Joy, 2010, Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis, Mol Carcinog, 49, 324, 10.1002/mc.20599

Muntener, 2004, Exon skipping of cathepsin B: mitochondrial targeting of a lysosomal peptidase provokes cell death, J Biol Chem, 279, 41012, 10.1074/jbc.M405333200

Baskin-Bey, 2005, Cathepsin B inactivation attenuates hepatocyte apoptosis and liver damage in steatotic livers after cold ischemia-warm reperfusion injury, Am J Physiol Gastrointest Liver Physiol, 288, G396, 10.1152/ajpgi.00316.2004

Li, 2008, The lysosomal–mitochondrial axis in free fatty acid-induced hepatic lipotoxicity, Hepatology, 47, 1495, 10.1002/hep.22183

Crouser, 2006, Carbamoyl phosphate synthase-1: a marker of mitochondrial damage and depletion in the liver during sepsis, Crit Care Med, 34, 2439, 10.1097/01.CCM.0000230240.02216.21